MedTrace Logo

Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

NCT00839696 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2019-11-19

No results posted yet for this study

Summary

Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.

Conditions

  • Breast Cancer Risk

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Amy Trentham Dietz, PhD · Associate Professor- Population Health Sciences, UW School of Medicine and Public Health

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-06-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00839696 on ClinicalTrials.gov